Skip to main content
. 2025 Apr 29;15(5):278. doi: 10.3390/bios15050278
ADL adalimumab
AAA Anti-adalimumab antibodies
SPR Surface plasmon resonance
TNF-α Tumor necrosis factor-alpha (TNF-α)
FDA Food and Drug Administration
EMA European Medicines Agency
JIA Juvenile Idiopathic Arthritis
NHS N-hydroxysuccinimide
EDC 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide
RU Resonance Units
MTX Methotrexate